Herein, we firstly presented a case about pancreatic ductal adenocarcinoma patient concurrent to targetable rare somatic novel KANK1-ALK, UPP2-NTRK3 fusion, and pathogenetic germline BRCA mutation. The gene discussed is NTRK3; the disease is pancreatic ductal adenocarcinoma.